The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications
Open accessPublished version of a preprint
Abstract
Introduction: The infection fatality rate (IFR) of COVID-19 has been carefully measured and analysed in high-income countries, whereas there has been no systematic analysis of age-specific seroprevalence or IFR for developing countries. Methods: We systematically reviewed the literature to identify all COVID-19 serology studies in developing countries that were conducted using representative samples collected by February 2021. For each of the antibody assays used in these serology studies, we identified data on assay characteristics, including the extent of seroreversion over time. We analysed the serology data using a Bayesian model that incorporates conventional sampling uncertainty as well as uncertainties about assay sensitivity and specificity. We then calculated IFRs using individual case reports or aggregated public health updates, including age-specific estimates whenever feasible. Results: In most locations in developing countries, seroprevalence among older adults was similar to that of younger age cohorts, underscoring the limited capacity that these nations have to protect older age groups. Age-specific IFRs were roughly 2 times higher than in high-income countries. The median value of the population IFR was about 0.5%, similar to that of high-income countries, because disparities in healthcare access were roughly offset by differences in population age structure. Conclusion: The burden of COVID-19 is far higher in developing countries than in high-income countries, reflecting a combination of elevated transmission to middle-aged and older adults as well as limited access to adequate healthcare. These results underscore the critical need to ensure medical equity to populations in developing countries through provision of vaccine doses and effective medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These impacts are less well understood in low- and middle-income countries [1–4], where routine mortality surveillance before the pandemic was patchy [5–7].”
From Estimates of pandemic excess mortality in India based on civil registration data (2022) · cites this paper as [3]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Many causes have exhibited a reduced geographical reach—a reflection of dedicated and persistent mitigation efforts to reduce the burden of certain causes, as well as potential changes to risk-factor exposure.15”
From Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Fernández de Larrea, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31483-5 · Cited by 1,639
Spread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Age-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
ESTIMATING PREVALENCE FROM THE RESULTS OF A SCREENING TEST
ROGAN, W. J., & GLADEN, B. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112510 · Cited by 1,001
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H., De Ridder, D., Petrovic, D., Schrempft, S., Marcus, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31304-0 · Cited by 990
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
Self-citationKarlinsky, A., & Kobak, D. (2021) · eLife · doi:10.7554/elife.69336 · Cited by 772
Research works printed but not linked: 4
- 10.7754/eLife.69336 · doi:10.7754/elife.69336
- Gill CJ . Latest data from Lusaka morgue analysis shows spike in COVID-19 deaths. The Conversation 2021. · doi:10.64628/aaj.uryknwxwe
- 10.1016/j.ypmed.2020.106331 · doi:10.1016/j.ypmed.2020.106331 · Paper page
- AAMd S , Lima-Neto LG , CdMPeSd A . Population-Based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the state of Maranhão, Brazil. medRxiv 2020.
Cited by
Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00367-2 · Cited by 2,889
“6,16,17 Although heterogeneity in COVID-19 outcomes in 2020 and 2021 varied by the income status of a country or territory, outcomes were also directly related to age, government actions to close borders, and the implementation of transmission-reduction policies.”
BackgroundGlobal impact of the first year of COVID-19 vaccination: a mathematical modelling study
Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00320-6 · Cited by 1,769
Ahmed, N., Marriott, A., Dabi, N., Lowthers, M., Lawson, M., & Mugehera, L. (2022) · doi:10.21201/2022.8465 · Cited by 198
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
Pezzullo, A. M., Axfors, C., Contopoulos‐Ioannidis, D. G., Apostolatos, A., & Ioannidis, J. P. A. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114655 · Cited by 123
Herrera, D., & Campos, G. D. L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07262-0 · Cited by 81
Metadata
- Authors
- Levin, A. T., Owusu-Boaitey, N., Pugh, S., Fosdick, B. K., Zwi, A. B., Malani, A., Soman, S., Besançon, L., Kashnitsky, I., Ganesh, S., McLaughlin, A., Song, G., Uhm, R., Herrera-Esposito, D., de los Campos, G., Peçanha Antonio, A. C., Tadese, E. B., & Meyerowitz-Katz, G.
- Affiliations
- Dartmouth College (US)
- School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
- Colorado State University (US)
- UNSW Sydney (AU)
- National Bureau of Economic Research (US)
- University of Chicago (US)
- Monash University (AU)
- University of Southern Denmark (DK)
- Laboratorio de Neurociencias, Universidad de la República, Montevideo, Uruguay
- Department of Epidemiology & Biostatistics, Michigan State University, East Lansing, Michigan, USA
- Adult Intensive Care Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- Ethiopian Public Health Institute (ET)
- Western Sydney Diabetes, Western Sydney Local Health District, Blacktown, New South Wales, Australia
- ORCID
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2022-05
- Volume
- 7
- Issue
- 5
- Pages
- e008477
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W4281556556
- Cited by
- 208
- References
- 88
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 59 · 2023: 61 · 2022: 41
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Global Health (publishedVersion, cc-by-nc)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc)
- Research Online (University of Wollongong) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, infection fatality rate, seroprevalence, developing countries, seroreversion, antibody assays, health care access, age structure, health equity, vaccine equity, public health policy
- MeSH terms
- COVID-19, Aged, Bayes Theorem, Developing Countries, Health Services Accessibility, Humans, Middle Aged, Public Policy, Seroepidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. https://app.cochat.ai/papers/10.1136/bmjgh-2022-008477
- The paper
- Levin, A. T., Owusu-Boaitey, N., Pugh, S., Fosdick, B. K., Zwi, A. B., Malani, A., Soman, S., Besançon, L., Kashnitsky, I., Ganesh, S., McLaughlin, A., Song, G., Uhm, R., Herrera-Esposito, D., de los Campos, G., Peçanha Antonio, A. C., Tadese, E. B., & Meyerowitz-Katz, G. (2022). Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. https://doi.org/10.1136/bmjgh-2022-008477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.